This protein can provide valuable insight for personalised treatment regimens, as high levels of protein S have been found to cause resistance to treatment which stimulates prostate cancer cells through cAMP or IL‐6‐inducing agents [165]. This evidence concerns the gene PROS1 and prostate carcinoma.